Long-term study of indolent adult T-cell leukemia-lymphoma
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The long-term prognosis of indolent adult T-cell leukemia-lymphoma (ATL) is not clearly elucidated. From 1974 to 2003, newly diagnosed indolent ATL in 90 patients (65 chronic type and 25 smoldering type) was analyzed. The median survival time was 4.1 years; 12 patients remained alive for more than 10 years, 44 progressed to acute ATL, and 63 patients died. The estimated 5-, 10-, and 15-year survival rates were 47.2%, 25.4%, and 14.1%, respectively, with no plateau in the survival curve. Although most patients were treated with watchful waiting, 12 patients were treated with chemotherapy. Kaplan-Meier analyses showed that advanced performance status (PS), neutrophilia, high concentration of lactate dehydrogenase, more than 3 extranodal lesions, more than 4 total involved lesions, and receiving chemotherapy were unfavorable prognostic factors for survival. Multivariate Cox analysis showed that advanced PS was a borderline significant independent factor in poor survival (hazard ratio, 2.1, 95% confidence interval, 1.0-4.6; P = .06), but it was not a factor when analysis was limited to patients who had not received chemotherapy. The prognosis of indolent ATL in this study was poorer than expected. These findings suggest that even patients with indolent ATL should be carefully observed in clinical practice. Further studies are required to develop treatments for indolent ATL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the revolution in molecular anti-cancer therapies in the 21st century, the prognosis of ATL remains poor [192].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [192]
Citations
Cites
1 retracted
Mori, N., Matsuda, T., Tadano, M., Kinjo, T., Yamada, Y., Tsukasaki, K., Ikeda, S., Yamasaki, Y., Tanaka, Y., Ohta, T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4582-4590.2004 · Cited by 60
Self-citationRetractedIARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Shimoyama, M., & members of The Lymphoma Study Group (1984–87) (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08051.x · Cited by 1,608
IARC monographs on the evaluation of carcinogenic risks to humans
(1996) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)89591-8 · Cited by 1,083
Yoshida, M., Seiki, M., Yamaguchi, K., & Takatsuki, K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2534 · Cited by 891
Tsukasaki, K., Utsunomiya, A., Fukuda, H., Shibata, T., Fukushima, T., Takatsuka, Y., Ikeda, S., Masuda, M., Nagoshi, H., Ueda, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9958 · Cited by 493
Self-citationDepletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A., & Liu, Y.-J. (2001) · Blood · doi:10.1182/blood.v98.4.906 · Cited by 398
(2003) · PubMed · Cited by 355
Yamada, Y., Tomonaga, M., Fukuda, H., Hanada, S., Utsunomiya, A., Tara, M., Sano, M., Ikeda, S., Takatsuki, K., Kozuru, M., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02737.x · Cited by 354
Self-citationTreatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa
Hermine, O., Bouscary, D., Gessain, A., Turlure, P., Leblond, V., Franck, N., Buzyn-Veil, A., Rio, B., Macintyre, E., Dreyfus, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322604 · Cited by 265
Research works printed but not linked: 3
- Dale, 2006, Neutropenia and neutrophilia., 907
- Wardlaw, 2006, Eosinophils and their disorders., 863
- Tobinai, 2004, Adult T-cell leukemia-lymphoma., 3109
Cited by
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Ishitsuka, K., & Tamura, K. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70202-5 · Cited by 343
Treatment and survival among 1594 patients with ATL
Katsuya, H., Ishitsuka, K., Utsunomiya, A., Hanada, S., Eto, T., Moriuchi, Y., Saburi, Y., Miyahara, M., Sueoka, E., Uike, N., et al. (2015) · Blood · doi:10.1182/blood-2015-03-632489 · Cited by 315
Self-citationMatsuoka, M., & Jeang, K.-T. (2011) · Oncogene · doi:10.1038/onc.2010.537 · Cited by 268
How I treat adult T-cell leukemia/lymphoma
Bazarbachi, A., Suarez, F., Fields, P., & Hermine, O. (2011) · Blood · doi:10.1182/blood-2011-03-345702 · Cited by 169
Komohara, Y., Niino, D., Saito, Y., Ohnishi, K., Horlad, H., Ohshima, K., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12167 · Cited by 113
Metadata
- Authors
- Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., Tomonaga, M., & Tsukasaki, K.
- Affiliations
- Nagasaki University (JP)
- Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology and
- Department of Hematology, Hirado Municipal Hospital, Nagasaki, Japan
- Japanese Red Cross Nagasaki Genbaku Hospital (JP)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-06-03
- Volume
- 115
- Issue
- 22
- Pages
- 4337-4343
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2006933182
- Cited by
- 180
- References
- 32
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 12 · 2020: 15 · 2019: 9 · 2018: 9 · 2017: 22 · 2016: 8 · 2015: 18 · 2014: 12 · 2013: 12 · 2012: 11
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
- Keywords
- prognosis, survival, prognostic factors, performance status, neutrophilia, lactate dehydrogenase, extranodal lesions, chemotherapy, expectant management, long-term follow-up
- MeSH terms
- Female, Follow-Up Studies, Humans, Japan, Male, Middle Aged, Prognosis, Leukemia-Lymphoma, Adult T-Cell, Proportional Hazards Models, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term study of indolent adult T-cell leukemia-lymphoma. https://app.cochat.ai/papers/10.1182/blood-2009-09-242347
- The paper
- Takasaki, Y., Iwanaga, M., Imaizumi, Y., Tawara, M., Joh, T., Kohno, T., Yamada, Y., Kamihira, S., Ikeda, S., Miyazaki, Y., Tomonaga, M., & Tsukasaki, K. (2010). Long-term study of indolent adult T-cell leukemia-lymphoma. Blood. https://doi.org/10.1182/blood-2009-09-242347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.